Articles about 'GSK'

Professor Duncan Richards appointed as Head of Department of Medicine

06 December 2024

Professor Duncan Richards has today been announced as the new Head of the Department of Medicine at the Cambridge City Campus.

Professor David Thomas and Dr Nicolas Wisniacki

Cambridge and GSK announce new five-year collaboration aiming for improved outcomes for patients with hard-to-treat kidney and respiratory diseases

21 October 2024

The ambition of the partnership is to treat immune-related diseases more precisely with existing therapies and to rapidly develop new ones.

Apollo Therapeutics secures $226.5 million to translate fundamental research into medicines

06 September 2023

Apollo Therapeutics, a biopharmaceutical company originally set up by three UK universities (Cambridge, Imperial College London and University College London) and three pharmaceutical companies (AstraZeneca, GSK and Johnson & Johnson Innovation), has secured $226.5 million venture capital financing.

Training a new breed of clinical triallist

03 February 2022

Cambridge's Experimental Medicine Initiative, working with AstraZeneca and GSK, is training specialists who can work out at an earlier stage of clinical trials if a treatment is likely to succeed.

One man, three companies, tens of thousands of lives...

22 October 2021

Professor Steve Jackson talks about drug discovery, serial entrepreneurship and the enterprising mindset.

“Behind every COVID-19 test sample is a person worried about their results”

04 September 2020

Meet the volunteer scientists who turn swab samples into diagnoses – again and again and again.

Tackling COVID-19: Karl Wilson

21 May 2020

Operations Director Karl Wilson has helped lead a herculean effort to transform a standard laboratory into a bespoke testing centre, to aid the national response against COVID-19. For him, there was never any question about whether we should - or could - do this.

AstraZeneca/GSK/Cambridge City Campus collaborate to support UK national effort to boost COVID-19 testing

07 April 2020

As part of the UK Government’s announcement of a new five pillar plan to boost testing for COVID-19, AstraZeneca, GSK and the Cambridge City Campus have formed a joint collaboration to take action to support this national effort.

Articles about 'GSK'

Professor Duncan Richards appointed as Head of Department of Medicine

Cambridge and GSK announce new five-year collaboration aiming for improved outcomes for patients with hard-to-treat kidney and respiratory diseases

Apollo Therapeutics secures $226.5 million to translate fundamental research into medicines

Training a new breed of clinical triallist

One man, three companies, tens of thousands of lives...

“Behind every COVID-19 test sample is a person worried about their results”

Tackling COVID-19: Karl Wilson

AstraZeneca/GSK/Cambridge City Campus collaborate to support UK national effort to boost COVID-19 testing

Connect with us

Study at Cambridge

About the University

Research at Cambridge